The genomics of preterm birth: from animal models to human studies by Bezold, Katherine Y. et al.
Preterm birth: scope, impact and risk factors
Signifi cant advances in elucidating disease pathogenesis 
and developing personalized therapies in oncology, 
pharmacology, cardiovascular biology, diabetes and other 
adult disorders have been facilitated by genomic medi­
cine. However, so far, there has been relatively little appli­
cation of genomic medicine to pregnancy and early child­
hood health. Th rough the use of genetic and genomic 
analytic techniques, the pathogenesis of human preterm 
birth ­ defi ned as delivery before 37 weeks of completed 
gestation  ­ may be elucidated, paving the way for the 
identifi cation of women at high risk of preterm delivery 
and for the development of personalized therapies.
Th e biology of human birth is a complex, poorly 
understood process, the disruption of which confers an 
increased potential for the development of severe health 
problems in both infants and mothers. Th is disruption 
leads to anomalous parturition, which encompasses 
several potentially adverse pregnancy outcomes, includ­
ing preeclampsia, fetal growth restriction, infections and, 
commonly, spontaneous preterm birth. Th e rate of 
preterm birth in the United States, after having increased 
by 20% to 12.8% of all births between 1990 and 2006 [1], 
has declined for the fi fth consecutive year since its 2006 
peak, and is now 11.7% [2]. Late preterm infants ­ those 
born between 34 0/7 weeks (that is, exactly 34 weeks) and 
36 6/7 weeks (or one day short of 37 weeks) of gestation ­ 
account for approximately 75% of all cases of preterm 
birth [3]. It is in this late preterm population that preterm 
birth rates in the United States have been declining, 
which is largely attributable to changes in obstetrics 
practices for medically indicated preterm deliveries 
rather than enhanced understanding of the underlying 
mechanisms of preterm birth. Th e rate of preterm birth 
for pregnancies delivering before 34  weeks of gestation 
remained unchanged over the same time period. 
Progesterone supplementation to specifi c subgroups of 
high­risk women may be eff ective in delaying birth, 
although this intervention has relatively little impact on 
overall prematurity rates [4]. Nonetheless, the reduction 
in late preterm birth is a signifi cant advance in infant 
health. Although the frequencies of respiratory distress 
syndrome, sepsis and apnea of prematurity are lower in 
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Further advances in understanding fundamental 
mechanisms, and the development of preventative 
measures, will depend upon the acquisition of greater 
numbers of carefully phenotyped pregnancies, large-
scale informatics approaches combining genomic 
information with information on environmental 
exposures, and new conceptual models for studying 
the interaction between the maternal and fetal 
genomes to personalize therapies for mothers and 
infants. Information emerging from these advances will 
help us to identify new biomarkers for earlier detection 
of preterm labor, develop more eff ective therapeutic 
agents, and/or promote prophylactic measures even 
before conception.
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preterm infants born at 36  weeks than those born at 
34 weeks [5], infants categorized as late preterm are more 
likely than their term counterparts to experience diffi­
culties with feeding, jaundice and respiratory distress [6] 
(Table  1). In addition to being particularly prone to 
infection as well as to metabolic and respiratory compli­
ca tions, late preterm infants are six times more likely to 
die within their first week of life and three times more 
likely to die within their first year of life compared with 
infants born at term [3].
Initiation of parturition before 37  weeks of gestation, 
most often occurring for an unidentifiable reason [7], 
may manifest as spontaneous labor or preterm premature 
rupture of membranes [7,8]. Controversy exists as to 
whether these two phenotypes reflect the same under­
lying pathology or distinct mechanisms. Although the 
pathogenesis of preterm labor is not well understood, a 
plethora of maternal risk factors associated with a higher 
incidence of preterm birth have been identified, including 
classification as black or African­American, maternal 
stress, maternal age, tobacco use and surgical interven­
tion for cervical disease [7,9,10] (Table 2).
One important maternal risk factor for preterm labor 
may be grounded in genetics (Table  2). The risk of a 
woman giving birth preterm is almost doubled if her 
sister has given birth to a preterm infant [11]. Mothers 
who were themselves born preterm are more likely to 
deliver preterm [12]. The maternal risk of delivering an 
infant preterm is four times higher if one of her previous 
children was delivered preterm [11]. However, the risk 
for a woman delivering preterm is unaffected by the 
history of preterm children of her partner with other 
women or by members of her partner’s family [13].
To begin to pare apart the pathogenesis of preterm 
labor, the use of mouse, rat, guinea pig, sheep and non­
human primate models has been useful. However, each 
model organism has certain disadvantages that make it 
difficult to portray and study human preterm labor accu­
rately [14,15]. Because of the disadvantages of drawing 
comparisons between the pathophysiology of preterm 
birth in animal models and humans, coupled with the 
strong genetic foundation of preterm labor, it may be 
most effective to use human genetics and genomics to 
elucidate the mechanisms underlying preterm birth.
Understanding the determinants of a healthy preg nan cy 
is necessary for transformative advances in women’s and 
infants’ health. A healthy pregnancy requires both con­
served structural and, more uniquely, temporal compo­
nents. The temporal components ­ the programming that 
determines birth timing  ­ will serve as the focus of this 
review. We will describe mechanistic findings that have 
emerged from animal studies, their limitations as applied 
to human parturition, evidence for genetic contributors 
to the risk for preterm birth in humans, and available 
results from human genetic and genomic investigations. 
We conclude with potential areas that could prove 
fruitful in further elucidating the genomics of preterm 
birth in the future.
Animal models: uses and limitations
The use of animal models to study the events leading up 
to and throughout birth has provided significant insight 
into the mechanisms regulating parturition, at term and 
preterm. However, the applicability of current animal 
models of parturition to the physiological mechanisms of 
human pregnancy and birth has been limited, as the 
means by which these different species regulate and 
initiate parturition differ from each other and from 
humans.
Perhaps the longest established animal model for birth 
timing is in sheep. The study of parturition in sheep is 
particularly relevant to human birth in that the gestation 
length and number of offspring per gestation is closer to 
that of humans than most of the common models in use, 
the sheer size of pregnant ewes and their fetuses make 
experimental manipulation easy, and a shift in the site of 
progesterone production from the corpus luteum of the 
ovary to the placenta occurs during pregnancy in both 
women and ewes [16]. However, in contrast to the human 
simplex uterus, sheep have a bicornuate uterus, allowing 
them to maintain one or two fetuses per gestation, and a 
cotyledonary placenta as opposed to a discoid placenta, 
as found in primates, indicating that the mechanisms 
controlling parturition in sheep may be different from 
Table 1. Complications associated with preterm birth 
Complication Percentage of Infants Affected Reference
Respiratory distress syndrome 10.5% for infants born at 34 weeks of gestation [70]
Sepsis Cumulative incidences of early and late onset sepsis are 4.42 and 6.30 episodes per 1,000 admissions  [71] 
 in late preterm infants
Apnea of prematurity 7% of infants born at 34 to 35 weeks of gestation, 15% at 32 to 33 weeks, 54% at 30 to 31 weeks, and  [72] 
 nearly all infants <29 weeks gestation
Necrotizing enterocolitis  Average of 11% between 22 and 28 weeks of gestation [73]
Patent ductus arteriosis  Average of 46% between 22 and 28 weeks of gestation [73]
Bronchopulmonary dysplasia Variation from 12 to 32% in infants born at less than 32 weeks of gestation [74]
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those in humans. Previous studies in ewes have also 
shown that parturition events depend on fetal regulation 
through the hypothalamic­pituitary­adrenal axis that 
ultimately result in a decrease in circulating maternal 
pro gesterone levels, that is, overt progesterone with­
drawal [16], which does not occur in human parturition, 
limiting the usefulness of sheep for modeling the events 
of human parturition and preterm birth (Table 3).
The use of mice has proven useful to further our 
understanding of the events leading up to parturition 
owing to the ease with which the mouse genome can be 
manipulated. Genes with the potential to influence par­
turi tion have been targets for the generation of knockout 
models. Several components of the cascade of events that 
occur during birth are conserved in both mice and 
humans (Figure 1), including prostaglandins, which serve 
as uterine contractile agonists, and contraction­asso­
ciated proteins (CAPs), which activate the myometrium 
and facilitate its response to stimulants [17]. Mice 
deficient in enzymes necessary for the synthesis of 
prostaglandins  ­ cytoplasmic phospholipase A2 (cPLA2) 
and cyclooxygenase 1 (COX1), for example ­ have shown 
delayed labor, which can be reversed by treatment with a 
progesterone receptor antagonist or by administration of 
exogenous prostaglandin F2α (PGF2α), which stimulates 
luteolysis (degeneration of corpus luteum function for 
progesterone synthesis) [18­21]. The significance of prosta­
glandins as uterine contractile agonists has been shown 
in studies of mice with reduced 15­hydroxyprostaglandin 
dehydrogenase (15­HPGD)  ­ an enzyme responsible for 
the metabolism of PGF2α as well as prostaglandin E2 
(PGE2)  ­ the expression of which has been shown to 
decrease in the chorionic trophoblast of women in labor 
[22­25]. These mice deliver a day early without luteolysis, 
as demonstrated by a lack of progesterone­withdrawal­
induced labor [26]. At term, the expression of CAPs such 
as the oxytocin receptor (OXTR) and connexin 43 
(CX43) in humans and mice increases in the myometrium 
[27]. Although the loss of oxytocin and OXTR in mice 
does not alter parturition [28­30], the concomitant loss 
of oxytocin and COX1 in mice leads to prolonged 
parturition that starts at normal term. This suggests that 
oxytocin maintains a luteotrophic role opposing the 
luteolytic role of COX1, which affects the presence of the 
contractile agonist PGF2α, allowing for normal proges­
terone withdrawal in these mice [21]. The loss of CX43 
(responsible for coordinating contractions in myometrial 
cells during labor) in smooth muscle tissues leads to 
slightly delayed parturition, even though these mice 
experi enced normal upregulation of OXTR and proges­
terone withdrawal [31]. Despite the similarities, the 
physio logy of pregnancy and birth differ significantly 
between mice and humans. Mice have a bicornuate 
uterus and tend to have large litters (typically ranging 
from six to eight pups), and thus the mechanism(s) of 
uterine activation are likely to differ from that of humans. 
The primary source of steroid hormone production in 
mice is the corpora lutea of the ovaries throughout preg­
nancy, whereas humans undergo a luteal­placental shift 
of steroid production during pregnancy. Additionally, 
before parturition mice undergo progesterone with­
drawal, limiting the relevance of pregnancy and parturi­
tion studies of this model organism to humans (Table 3).
Perhaps not as commonly used in research as the 
mouse and rat, the study of parturition in guinea pigs has 
revealed this process to be more similar to that of 
humans than in mice or rats. Through the duration of 
gestation up until parturition, guinea pigs maintain high 
levels of maternal serum progesterone and, consequently, 
do not require progesterone withdrawal to initiate labor, 
similar to human labor. Also like humans, guinea pigs 
have a hemomonochorial type of placentation, and the 
placenta, after the first four weeks of gestation, is the 
predominant source of progesterone [15]. Although a 7X 
coverage genome sequence has recently become avail­
able, the use of guinea pigs to model human parturition 
and preterm birth is limited owing to a relatively long 
gestation length (67 days) relative to other rodent models, 
thus increasing the length of time required to perform 
experiments, as well as limited protein and cDNA 
reagents, and suboptimal molecular genetic techniques 
for use on this model system (Table 3).
Non­human primates present a more analogous model 
organism for the study of parturition and preterm birth 
as their reproductive biology is most similar to that of 
humans. Rhesus macaques, like humans, do not undergo 
maternal serum progesterone withdrawal at term. Great 
apes and humans experience a continual rise in proges­
terone concentration throughout the pregnancy, peaking 
at term, in comparison to Old World monkeys, which 
have basally low, unchanging levels of progesterone, and 
New World monkeys, which undergo progesterone with­
drawal [27]. Although non­human primates are physio­
logically representative model organisms to understand 
Table 2. Risk factors associated with preterm birth
 Relative risk 
Risk factor (95% CI) Reference
Ethnicity (African-American) 1.3 (1.0 to 1.6) [75]
Maternal stress 3.3 (1.2 to 9.4) [76]
Maternal age 2.1 (1.3 to 3.6) [77]
Tobacco use 1.3 (1.2 to 1.3) [78]
Surgical intervention for cervical disease 1.3 (1.3 to 1.4) [79]
Genetics: previous preterm birth 5.6 (5.5 to 5.8) [13]
Genetics: maternal family history of  1.6 (1.5 to 1.6) [13] 
preterm birth
CI, confidence interval.
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human parturition and preterm birth, the expense and 
time necessary to maintain and study these animals as 
well as their long gestation periods (greater than 
5 months), the unfeasibility of genetic manipulation, and 
the lack or limitation of optimized reagents make their 
use less practical (Table 3).
Although the currently employed model organisms for 
parturition and preterm birth have their benefits, perhaps 
the best model for human parturition and preterm birth 
is humans themselves. Analyses of sequences across 
human, chimpanzee and mouse genomes indicate that 
one of the most divergent functional categories includes 
the genes involved in reproduction [32]. The use of com­
putational biology coupled with the rapidly expanding 
availability of mammalian genomes opens the possibility 
of isolating rapidly diverging genes or conserved non­
coding sequences that may be relevant to human par­
turition, and identifying interesting variants in genome­
wide association studies, which would provide potential 
targets that may determine birth outcome [27].
A role for genetics in human preterm birth
Preterm birth is etiologically complex, with contributions 
from the environment and genetics, which could involve 
both maternal and fetal genomes [33]. The analysis of 
birth timing concordance in the offspring of twins demon­
strated that both maternal and fetal genetic effects con tri­
buted to defining the variance in gestational age (Table 4) 
[33]. By studying correlations between genetic relatedness 
and trait concordance, genetic effects are calculated to 
account for 25 to 40% of variation in fetal growth rate and 
gestation duration; additionally, birth weight, small size 
for gestational age, and preterm birth had significant 
genetic contributions [34]. Comparisons between full 
siblings and half siblings facilitate studies of variable 
related ness within a shared environment, allow ing for the 
study of genetic contribution as well as differ ences 
between maternal genetic contribution (cal cu lated at 14%) 
and fetal genetic contribution (calculated at 11%) [35].
Preterm birth is a trait that appears to be transmitted 
primarily in a matrilineal manner across generations; the 
risk of a woman having a preterm delivery is increased if 
her mother, full sisters or maternal half­sisters have had 
preterm deliveries, but is unaffected by the occurrence of 
preterm deliveries in her paternal half­sisters or in 
members of her partner’s family [13]. Birth before 
37  weeks of gestation increases a woman’s own risk of 
preterm delivery by almost 20% [11], and having a 
previous preterm delivery confers an increased risk of 
recurrent preterm delivery [13]. Although the paternal 
contribution to birth timing in the context of fetal genetic 
influences has been somewhat controversial, data suggest 
a smaller role for paternal compared with maternal fetal 
genes in birth timing [36,37].
On the basis of this evidence of a genetic component in 
the timing of birth, genetic studies have investigated both 
maternal and fetal genomes, as both genotypes can affect 
perinatal outcomes [38]. Thus far, most human genetics 
Table 3. Comparison of human parturition and preterm birth with animal models
 Source of Fall in serum Gestation    
 progesterone in progesterone length Number Sequenced  
Species late gestation at term (days) of fetuses genome Comments
Human Placenta No 266 1 Yes Excellent model for genomic studies, 
complicated by complex environmental factors 
Guinea pig Placenta No 67 1 to 6  
(average 3)
Yes A lengthy gestation period (in comparison with 
other rodents) and lack of optimized reagents 
limits the use of this organism as a model of 
preterm birth 
Mice Corpus luteum of 
the ovary
Yes 19.5 6 to 8 Yes A short gestation length, optimized reagents, 
and easily manipulated genetics make this 
model ideal to work with. However, the 
necessity of progesterone withdrawal before 
the onset of labor limits its applicability to 
human parturition
Rhesus 
macaque
Placenta No 164 1 Yes Lack of optimized reagents, the expense and 
time to maintain and study this organism, and 
the unfeasibility of genetic manipulation make 
the use of this model impractical 
Sheep Placenta Yes 147 1 to 2 Yes Labor is preceded by progesterone withdrawal, 
which differs from human parturition. This 
model is expensive to maintain, limiting the 
number of animals that can be used per 
experiment
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studies with respect to birth timing have focused on 
comparing polymorphism frequencies in case­control 
studies, with preterm versus term birth as the dichoto­
mous trait outcome [39]. To elucidate further the role of 
genetics in birth timing, candidate genes have been 
analyzed in a multitude of pathways that are thought to 
be involved in parturition. Several recent comprehensive 
reviews of candidate gene association studies have been 
published [39­41]. Below, we provide representative 
exam ples of a subset of these studies, followed by dis­
cussion of genome­wide approaches.
Candidate gene studies
Perhaps the most commonly studied pathways for 
potential candidate genes are those involved in immunity 
and infl ammation, as infl ammatory factors have been 
suggested to play a role early in the transition from 
quiescence to active labor in term as well as preterm 
birth [42]. Th e induction of pro­infl ammatory mediators 
has been implicated in the onset of parturition, parti cu­
larly tumor necrosis factor (TNF)­α and its receptors 
(TNFR1 and TNFR2). Although some studies have 
detected polymorphisms in these genes that alter the risk 
Figure 1. Comparison of mouse and human parturition. (a) In mice, initial mechanisms for labor initiation include induction of uterine 
endometrial cyclooxygenase 1 (COX1) expression and reduction of uterine 15-hydroxyprostaglandin dehydrogenase (HPGD) expression. 
These changes in prostaglandin metabolism lead to elevated prostaglandin F2α (PGF2α), which acts on the ovarian corpus luteum to decrease 
circulating progesterone (P4). This systemic progesterone withdrawal results in induction of contraction-associated proteins (CAPs) and 
transition of the uterine myometrium from a quiescent to an actively contractile state. (b) In human pregnancy, labor initiation is associated 
with induction of amnion COX2 and placental corticotropin-releasing hormone (CRH) and a reduction in chorion HPGD. These changes in 
prostaglandin metabolism and peptide signaling are associated with increased amnion prostaglandin E2 (PGE2), pro-infl ammatory cytokines and 
estradiol. This pro-infl ammatory milieu is hypothesized to cause ‘functional’ progesterone withdrawal (circulating progesterone does not fall), 
or progesterone resistance, followed by induction of CAPs and labor. Note that several fundamental diff erences between human and mouse 
parturition exist beyond the diff erences in systemic progesterone regulation at term. Murine gestation is multi-fetal, whereas human gestation 
is predominantly single fetus. In mice, the sites of prostaglandin and progesterone synthesis are maternal, whereas in human pregnancy, the 
primary sites of prostaglandin and progesterone synthesis in late gestation are from fetal tissues. Adapted from [27], Ratajczak CK, Fay JC, Muglia LJ: 
Preventing preterm birth: the past limitations and new potential of animal models. Dis Model Mech 2010, 3:407-14 with permission from 
The Company of Biologists.
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for preterm birth in either the mother or fetus, the results 
have generally failed to be replicated [39] or have not 
been generalized across populations [43,44]. Analysis of 
pro­inflammatory and anti­inflammatory interleukins 
and their receptors have generally revealed no consistent 
association with preterm birth, with mixed results for 
inter leukin (IL)­4, ­6 and ­10 as well as for interleukin 
receptors 1 (IL1R) and 6 (IL6R) [39]. Examination of 
other cytokines and pathogen recognition genes has 
similarly not provided compelling evidence for asso­
ciation with preterm birth.
Another critical process for the initiation of parturition 
involves the transition of the uterus from a quiescent 
tissue, influenced by mediators that inhibit contraction, 
to a synchronously contracting tissue. Searching for can­
di date genes involved in premature uterine contraction 
has revealed the potential association of two polymor­
phisms in the gene encoding the β2­adrenergic receptor 
(ADRB2), which is responsible for modulating uterine 
muscle contractions through the promotion of smooth 
muscle relaxation in the uterus, with preterm birth risk 
[45­47]. Analysis of another molecule involved in uterine 
contraction, the dopamine receptor D2 (DRD2), did not 
reveal an association with preterm birth [40]. Further­
more, no links with preterm birth were established 
between the prostaglandin pathway genes prostaglandin E 
receptor 2 (PTGER2), prostaglandin E synthase (PTGES) 
or prostaglandin F receptor (PTGFR), despite the activity 
of prostaglandins in promoting uterine contractility [40].
As maintenance of pregnancy requires proper func­
tioning of the placenta, genes involved in angiogenesis 
and thrombosis have also been targets for association 
with preterm birth and placental dysfunction. One small 
study described a potential association between preterm 
birth risk and an intronic polymorphism in the vascular 
endothelial growth factor (VEGF) gene, which is 
responsible for inducing angiogenesis [48], but this has 
not been replicated in larger cohorts. Studies of hemo­
stasis genes have yielded mixed results: an identified 
association [40] for the gene encoding one factor (factor 
V, F5) was not replicated [45,49]; some studies identified 
genes encoding factors associated in infants only (factor 
XIII, F13A1; thrombomodulin, THBD) [45,50], or in both 
mothers and infants (factor VII, F7); and others were not 
associated with preterm birth at all (factor II, F2; protein 
C receptor, endothelial, PROCR; protein C, PROC; and 
tissue factor pathway inhibitor, TFPI) [45,50].
Although some advances have been made in studies of 
the genetic contributions to preterm birth using candi­
date gene approaches, concrete causal links between 
these polymorphisms and preterm birth have not been 
established. Recent meta­analyses have been performed 
and summarized, providing a useful resource for investi­
gators interested in the genetics of preterm birth [51,52]. 
Table 4. Genetic approaches to dissecting maternal and fetal contributions to birth timing 
 Contribution of genetics to birth timing
  Fetal Maternal 
Group Approach genes genes Summary Covariates Reference
Boyd et al. Population 
epidemiology
- ++ Women with a history of preterm birth (mothers, 
full sisters, or maternal half-sisters delivered 
preterm) were 55% more likely to deliver preterm
Yes [13]
York et al. Children of twins + + Both maternal and fetal genetic effects contribute 
to gestational age
No [33]
Clausson et al. Children of twins N/A + The heritability for preterm birth is approximately 
36%
No [34]
Lunde et al. Population 
epidemiology
+ + 11% of variation in gestational age can be 
explained by fetal genetic factors          Maternal 
genetic factors account for 14% of the variation in 
gestational age
Yes [35] 
Kistka et al. Children of twins - ++ Maternal genetic factors may contribute up to 
34% of variation in the timing of birth
No [37]
Wilcox et al. Population 
epidemiology
- ++ Mothers born preterm have a higher risk for 
preterm delivery whereas preterm fathers do not 
affect likelihood of child being born preterm. This 
suggests that paternal genes have little effect on 
preterm delivery risk, arguing against fetal genetic 
contributions
Yes [36]
Plunkett et al. Segregation 
analysis
+ ++ The maternal genome and possibly maternally 
inherited fetal genes influence birth timing
No [38] 
-, No evidence for genetic contribution; +, moderate genetic contribution; ++, strong genetic contribution.
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However, through the use of genome­wide tools and 
analysis techniques, previously unanticipated mechanisms 
may be revealed.
Genomic approaches to preterm birth
To elucidate new genes and pathways involved in normal 
and pathological parturition, non­biased, genome­wide 
approaches offer substantial promise. Below, we describe 
complementary approaches to identify both common 
and rare variants that increase risk for preterm birth, and 
their associated findings.
Genome-wide association studies
Genome­wide association studies (GWASs) are an un­
biased method for the discovery of new functional 
mecha nistic pathways in disease processes [53] such as 
preterm birth and abnormal fetal growth. Through meta­
analysis of six GWASs, variants in adenylyl cyclase type 5 
(ADCY5), which has pleiotropic effects on glucose 
regulation, and variants near cyclin L1 (CCNL1), which 
may be involved in pre­mRNA splicing and RNA pro­
cessing, have been shown to be associated with fetal 
growth and birth weight [54]. Furthermore, by looking 
genome wide at single nucleotide polymorphisms (SNPs) 
in a prioritized list that arose from a comparative analysis 
of genes showing divergence between humans and other 
mammals, a novel association between the follicle stimu­
lating hormone receptor gene (FSHR) and preterm birth 
was revealed [55]. GWAS data for approximately 1,000 
preterm birth cases and 1,000 controls is currently 
available from the Danish National Birth Cohort through 
the database of Genotypes and Phenotypes (dbGaP) for 
analysis [56]. However, in this dataset, gene variants with 
genome­wide statistical significance have not been found. 
Recent pathway­based, rather than gene­based, analyses 
using a custom database of genes curated from existing 
literature for preterm birth (dbPTB), have implicated 
several potentially relevant pathways that can be used to 
elucidate further gene­gene and gene­environment 
interactions [52,57]. Further meta­analysis with emerging 
new data from other groups should provide additional 
power for the detection of associations. Modest sample 
sizes, along with the inability to rigorously sub­phenotype 
preterm births into more homogeneous groups based on 
gestational age or potential etiology, has limited the 
impact of GWASs so far.
Mitochondrial genetics
One underexplored avenue for determining maternal risk 
for preterm birth involves the influence of the 
mitochondrial genome. The high mutation rate of mito­
chondrial DNA (mtDNA), together with the fact that 
most of its encoded proteins are evolutionarily con­
served, allowing for the selection of neutral or beneficial 
variants, has generated interest in defining human 
mtDNA variations and their roles in human biology [58]. 
The results of two mitochondrial genome scans from two 
European populations examining links between mito­
chon drial genotypes and preterm birth did not reveal any 
associations with preterm delivery and its related out­
comes [59]. Perhaps one of the most signifi cant limita­
tions of the study was the lack of data regarding pre­
defined haplogroups. As the transmission of mtDNA is 
uniparental due to the lack of recombination, patho genic, 
functional and neutral variants can interact and are often 
linked with one another [58]. Thus, a multitude of SNPs 
can accumulate along branches of a haplogroup, which 
may alter the significance of other sub­haplo groups; 
hence, the test for individual SNPs reveals an inadequate 
image of the evolutionary and functional role for mtDNA 
in an individual’s haplotype [58].
Rare variant analysis
As the variants detected by GWASs have typically 
explained only a minor proportion of the heritability of 
complex diseases, it may prove more informative to 
pursue the identification and association of rare variants 
with disease [60]. Although not as many examples as for 
common SNPs have been reported, rare variants have 
been shown to play a role in complex traits [60]. So far, 
the analysis of rare variants associated with preterm birth 
has been limited. In one study exploiting candidate gene 
linkage for 33 genes in 257 families, nonparametric and 
parametric analyses performed on 99 SNPs in premature 
infants and mothers of premature infants resulted in the 
identification of a moderate association with preterm 
birth of corticotropin releasing hormone receptor 1 
(CRHR1) and cytochrome P450 2E1 (CYP2E1) in affected 
infants, and with ectonucleotide pyrophosphatase/phos­
pho diesterase 1 (ENPP1), insulin­like growth factor bind­
ing protein 3 (IGFBP3), TNF receptor­associated factor 2 
(TRAF2) and 7­dehydrocholesterol reductase (DHCR7) 
in mothers [61]. DNA sequence analysis was performed 
for CRHR1 and TRAF2 to detect novel potentially 
causa tive mutations, but no new variants were detected 
[61].
Family-based designs
The use of family­based designs increases the power to 
detect associations, controls for heterogeneity/popula­
tion stratification, and might elucidate the effects of allele 
origin as well as transmission of phenotypes of disease 
modulation, allowing for the study of parent­of­origin 
effects [62]. Family­based linkage analysis, combined 
with case­control association studies, have been used to 
determine a susceptibility haplotype for preterm birth in 
Finnish multiplex (multiple individuals affected in 
different generations) and nuclear families [63]. Through 
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the use of parametric linkage analysis, genetic factors 
that influence preterm birth in either the fetus or mother 
may be elucidated by accounting for both potential 
mecha nisms of action of the preterm birth phenotype: 
being born preterm (an affected fetus or an infant 
phenotype); or giving birth preterm (an affected mother 
phenotype) (Figure  2) [59]. This method, followed by a 
case­control study and haplotype segregation analysis, 
identified a novel susceptibility gene (IGF1R) that, 
through the fetal genome, results in a predisposition to 
preterm birth [59]. Additionally, two X­linked genes were 
implicated when preterm birth was the studied 
phenotype: the androgen receptor (AR) and IL­2 receptor 
γ subunit (IL2RG) genes, which are located near a 
significant linkage signal locus (Xq13.1) [64]. Further 
analysis revealed long CAG repeats in the AR gene that 
were overrepresented, as well as short repeats that were 
underrepresented, in preterm individuals in comparison 
to term individuals, implicating this as a potential fetal 
susceptibility gene for preterm birth [64].
Figure 2. Two representations of affected status in the same pedigree with recurrent spontaneous preterm birth. Numbers indicate the 
gestational ages for each individual, in weeks. Circles indicate females and squares indicate males, diamonds indicate miscarriages. Preterm birth 
is indicated with closed (black) circles or squares, and question marks indicate unknown gestational ages. (a) Illustration of the pattern of affected 
status if the infant is proband for preterm birth. (b) Illustration of the pattern of affected status if the mother is proband for preterm birth. Modeling 
the incidence of maternal and infant phenotypes indicates that genetic influences on the timing of parturition are important and complex, and 
thus unlikely to be explained by a single gene model. Reproduced from [38] with permission from S Karger AG, Basel.
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Conclusions and future approaches
We have summarized recent findings from model 
organisms that have defined components of birth timing 
mechanisms for those species, and the evidence for 
variable maternal and fetal contributions to the process 
depending upon the species investigated. We further 
provide evidence that genetic variation contributes to 
preterm birth risk in humans and, as a corollary, that 
genomic approaches should prove fruitful for revealing 
key components of the molecular machinery controlling 
the duration of human gestation. Although currently 
employed genomic approaches have been useful in 
starting to unravel the complexity of birth timing, much 
remains to be learned by applying more thorough 
genome sequencing methods. One such approach is 
whole­exome sequencing [65]. Several efforts are 
currently underway in this regard. An initial report from 
our group analyzing exomes of ten mothers from families 
with recurrent instances of preterm birth, including two 
mother­daughter pairs, found that the complement/
coagulation factor pathway was enriched in harboring 
rare variants [66]. Whole­genome sequencing may pro­
vide the opportunity for the identification of regulatory 
elements as well as amino acid changes, although the 
scale of the necessary bioinformatic analysis remains 
formidable [67]. Large­scale genome sequencing studies, 
such as the Inova collaboration, are currently being 
planned and initiated to investigate de novo mutations in 
infants and contributions of the maternal genome to 
preterm birth [68]. The availability and synthesis of 
genomic data from preterm infants, controls and parents 
will significantly advance current understanding of the 
genomics of birth timing, paving the way for the 
determination of the mechanisms regulating the timing 
of parturition. What must not be overlooked in these 
future efforts is rigorous phenotyping and ascertainment 
of environmental exposures. Preterm birth is a very 
heterogeneous phenotype. Suitable numbers of individuals 
with more restricted phenotypes, including gestational 
age windows at birth, type of spontaneous delivery (spon­
taneous labor versus premature rupture of membranes), 
associated fetal growth characteristics or maternal 
characteristics, will greatly accelerate gene identification. 
To facilitate time­efficient collection of subject samples 
(mother, father and infant at a minimum; maternal 
grandparents and more extended family structure when 
likely to be informative) and phenotype data, more 
extended international collaborations with comprehen­
sive, standardized definitions and data fields are essential 
[69]. Ultimately, gene discovery in humans will require 
the innovative application of noninvasive methods during 
pregnancy, such as functional imaging, proteomics and 
metabolomics, as well as the generation and investigation 
of new preclinical model organisms and ex vivo systems, 
to establish mechanisms and define potential pro phy­
lactic interventions for preterm birth.
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